RecruitingNCT07226804
Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Sponsor
M.D. Anderson Cancer Center
Enrollment
30 participants
Start Date
Nov 14, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Questionnaire for people with pulsed field ablation and thyroid nodules. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERQuestionnaire
patient-reported outcomes questionnaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07226804
Related Trials
OPTION-EMEA Clinical Trial
NCT073491213 locations
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study
NCT051893141 location
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
NCT076017631 location
The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
NCT063409451 location
Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
NCT071307731 location